These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20798404)

  • 1. Occurrence of stavudine-induced lactic acidosis in 3 members of an African family.
    Fielder J; Rambiki K
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):236-9. PubMed ID: 20798404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lactic acidosis associated with stavudine administration: a report of five cases.
    Mokrzycki MH; Harris C; May H; Laut J; Palmisano J
    Clin Infect Dis; 2000 Jan; 30(1):198-200. PubMed ID: 10619755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
    Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
    AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acidosis and antiretroviral therapy: a case report and literature review.
    Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E
    Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore.
    Hwang SW; Leo YS
    Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactic acidosis secondary to nucleoside analogue antiretroviral therapy.
    Khouri S; Cushing H
    AIDS Read; 2000 Oct; 10(10):602-6. PubMed ID: 11068807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
    Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
    Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal lactic acidosis during antiretroviral therapy.
    Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
    Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for lactic acidosis in HIV-infected patients treated with nucleoside reverse-transcriptase inhibitors: a case-control study.
    Bonnet F; Bonarek M; Morlat P; Mercié P; Dupon M; Gemain MC; Malvy D; Bernard N; Pellegrin JL; Beylot J
    Clin Infect Dis; 2003 May; 36(10):1324-8. PubMed ID: 12746780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acidosis in HIV infected children due to antiretroviral therapy.
    Shah I
    Indian Pediatr; 2005 Oct; 42(10):1051-2. PubMed ID: 16269849
    [No Abstract]   [Full Text] [Related]  

  • 12. Stavudine-induced hyperlactatemia/lactic acidosis at a tertiary communicable diseases clinic in South Africa.
    Hernández Pérez E; Dawood H
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):109-12. PubMed ID: 20484736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside analogues and mitochondrial toxicity.
    Fleischer R; Boxwell D; Sherman KE
    Clin Infect Dis; 2004 Apr; 38(8):e79-80. PubMed ID: 15095236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperlactataemia in HIV-infected patients: the role of NRTI-treatment.
    Vrouenraets SM; Treskes M; Regez RM; Troost N; Smulders YM; Weigel HM; Frissen PH; Brinkman K
    Antivir Ther; 2002 Dec; 7(4):239-44. PubMed ID: 12553477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy].
    Justesen US; Pedersen C
    Ugeskr Laeger; 2000 Aug; 162(35):4664-5. PubMed ID: 10986895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. d4T plus ddI: warning for pregnant women.
    AIDS Treat News; 2001 Jan; (358):8. PubMed ID: 12173560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment.
    Cornejo-Juárez P; Sierra-Madero J; Volkow-Fernández P
    Arch Med Res; 2003; 34(1):64-9. PubMed ID: 12604378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
    Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
    Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.